Autologous Angiogenic Cell Precursors (ACPs) for the Treatment of Peripheral Artery Disease

Summary

Regeneration of the occluded peripheral arteries by autologous stem cell therapy is an emerging treatment modality for no-option patients with peripheral artery disease (PAD). The purpose of this study was to assess safety and efficacy of ex vivo expanded, peripheral blood-derived, autologous angiogenic cell precursors (ACPs) in no-option PAD patients.

Timeline

Start

2008-05

Primary completion

2009-04

Completion

2009-07

Drugs

Indications